jRCTs031210665
Untitled Trial
A Prospective Interventional Study to Evaluate the Effect of Sarilumab on Bone Destruction in Rheumatoid Arthritis Patients (APPRECIATE)
Japan Registry Clinical TrialRecruitment Completed
Study focus
- Disease/Condition
- Rheumatoid arthritis
- Study type
- Interventional
Sponsor & location
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Rheumatoid arthritis, unspecifiedOther rheumatoid arthritisOther specified rheumatoid arthritisRheumatoid arthritis with involvement of other organs and systemsSeronegative rheumatoid arthritis
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCTs031210665
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCTs031210665 through Pure Global AI's free database. This phase not specified trial is sponsored by sponsor not specified and is currently Recruitment Completed. The study focuses on Rheumatoid arthritis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.